Sartorius Historical Balance Sheet

0RG8 Stock

197.30 0.10 0.05%

Trend analysis of Sartorius Stedim Biotech balance sheet accounts such as Short Long Term Debt Total of 679.8 M, Total Current Liabilities of 642.1 M or Total Stockholder Equity of 1.2 B provides information on Sartorius Stedim's total assets, liabilities, and equity, which is the actual value of Sartorius Stedim Biotech to its prevalent stockholders. By breaking down trends over time using Sartorius Stedim balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Sartorius Stedim Inventory

1.24 Billion

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Sartorius Stedim Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Sartorius Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Sartorius Stedim Biotech at a specified time, usually calculated after every quarter, six months, or one year. Sartorius Stedim Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Sartorius Stedim and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Sartorius currently owns. An asset can also be divided into two categories, current and non-current.

Sartorius Stedim Balance Sheet Chart

At this time, Sartorius Stedim's Intangible Assets are comparatively stable compared to the past year.

Total Assets Short Long Term Debt Total Total Stockholder Equity Retained Earnings Cash Accounts Payable

Total Assets

Total assets refers to the total amount of Sartorius Stedim assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Sartorius Stedim Biotech books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.

Cash

Cash refers to the most liquid asset of Sartorius Stedim Biotech, which is listed under current asset account on Sartorius Stedim Biotech balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Sartorius Stedim customers. The amounts must be unrestricted with restricted cash listed in a different Sartorius Stedim account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.

Accounts Payable

An accounting item on the balance sheet that represents Sartorius Stedim obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Sartorius Stedim Biotech are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most accounts from Sartorius Stedim's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Sartorius Stedim Biotech current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Sartorius Stedim Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, Sartorius Stedim's Intangible Assets are comparatively stable compared to the past year.

	2019	2020	2024	2025 (projected)
Short and Long Term Debt Total	84.1M	562.9M	647.4M	679.8M
Total Assets	1.8B	3.1B	3.5B	2.0B

Short Long Term Debt Total Total Assets

Sartorius Stedim balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Total Current Liabilities	Total Stockholder Equity	Retained Earnings	Cash	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Short Term Investments	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment	Other Current Liab	Other Liab	Net Tangible Assets	Accounts Payable	Deferred Long Term Liab
Total Assets		0.91	0.94	0.99	0.9	0.92	0.82	0.91	0.99	0.93	0.99	0.23	0.83	0.87	0.86	0.91	0.83	0.91	0.53	0.95	0.92	0.91	-0.35	0.94	0.91
Short Long Term Debt Total	0.91		0.89	0.9	0.84	0.86	0.92	1.0	0.92	0.88	0.91	0.22	0.94	0.97	0.78	1.0	0.95	1.0	0.65	0.88	0.9	0.91	-0.49	0.93	0.88
Total Current Liabilities	0.94	0.89		0.93	0.95	0.89	0.89	0.89	0.95	0.99	0.94	0.19	0.9	0.88	0.82	0.88	0.91	0.88	0.58	0.97	0.99	0.96	-0.19	0.99	0.97
Total Stockholder Equity	0.99	0.9	0.93		0.88	0.85	0.85	0.9	0.96	0.93	0.96	0.38	0.84	0.88	0.92	0.91	0.84	0.9	0.58	0.94	0.9	0.89	-0.33	0.92	0.89
Retained Earnings	0.9	0.84	0.95	0.88		0.88	0.88	0.84	0.92	0.98	0.91	0.14	0.89	0.88	0.76	0.84	0.88	0.84	0.61	0.98	0.96	0.84	0.0	0.95	0.99
Cash	0.92	0.86	0.89	0.85	0.88		0.71	0.86	0.97	0.86	0.96	-0.15	0.76	0.79	0.62	0.84	0.76	0.85	0.46	0.89	0.89	0.87	-0.36	0.92	0.87
Other Assets	0.82	0.92	0.89	0.85	0.88	0.71		0.92	0.81	0.91	0.8	0.38	0.99	0.97	0.83	0.93	0.98	0.93	0.74	0.88	0.9	0.84	-0.19	0.91	0.91
Long Term Debt	0.91	1.0	0.89	0.9	0.84	0.86	0.92		0.92	0.87	0.91	0.21	0.94	0.97	0.77	1.0	0.94	1.0	0.65	0.88	0.9	0.91	-0.49	0.93	0.87
Cash And Short Term Investments	0.99	0.92	0.95	0.96	0.92	0.97	0.81	0.92		0.93	1.0	0.11	0.83	0.87	0.79	0.91	0.84	0.91	0.56	0.95	0.93	0.92	-0.36	0.96	0.92
Net Receivables	0.93	0.88	0.99	0.93	0.98	0.86	0.91	0.87	0.93		0.92	0.26	0.91	0.9	0.84	0.88	0.91	0.87	0.63	0.98	0.98	0.91	-0.11	0.98	0.98
Good Will	0.99	0.91	0.94	0.96	0.91	0.96	0.8	0.91	1.0	0.92		0.12	0.81	0.85	0.8	0.9	0.82	0.9	0.51	0.94	0.93	0.91	-0.36	0.95	0.91
Short Term Investments	0.23	0.22	0.19	0.38	0.14	-0.15	0.38	0.21	0.11	0.26	0.12		0.28	0.3	0.64	0.26	0.28	0.23	0.38	0.22	0.14	0.14	0.0	0.13	0.16
Inventory	0.83	0.94	0.9	0.84	0.89	0.76	0.99	0.94	0.83	0.91	0.81	0.28		0.98	0.77	0.95	1.0	0.95	0.74	0.9	0.92	0.87	-0.23	0.93	0.93
Other Current Assets	0.87	0.97	0.88	0.88	0.88	0.79	0.97	0.97	0.87	0.9	0.85	0.3	0.98		0.79	0.98	0.98	0.98	0.73	0.9	0.9	0.85	-0.31	0.92	0.91
Other Stockholder Equity	0.86	0.78	0.82	0.92	0.76	0.62	0.83	0.77	0.79	0.84	0.8	0.64	0.77	0.79		0.8	0.77	0.78	0.53	0.82	0.78	0.77	-0.22	0.79	0.78
Total Liab	0.91	1.0	0.88	0.91	0.84	0.84	0.93	1.0	0.91	0.88	0.9	0.26	0.95	0.98	0.8		0.95	1.0	0.67	0.88	0.89	0.91	-0.48	0.93	0.88
Total Current Assets	0.83	0.95	0.91	0.84	0.88	0.76	0.98	0.94	0.84	0.91	0.82	0.28	1.0	0.98	0.77	0.95		0.95	0.73	0.9	0.93	0.89	-0.26	0.94	0.92
Intangible Assets	0.91	1.0	0.88	0.9	0.84	0.85	0.93	1.0	0.91	0.87	0.9	0.23	0.95	0.98	0.78	1.0	0.95		0.67	0.88	0.89	0.91	-0.48	0.93	0.88
Common Stock	0.53	0.65	0.58	0.58	0.61	0.46	0.74	0.65	0.56	0.63	0.51	0.38	0.74	0.73	0.53	0.67	0.73	0.67		0.61	0.6	0.53	-0.17	0.62	0.65
Property Plant Equipment	0.95	0.88	0.97	0.94	0.98	0.89	0.88	0.88	0.95	0.98	0.94	0.22	0.9	0.9	0.82	0.88	0.9	0.88	0.61		0.97	0.9	-0.11	0.97	0.98
Other Current Liab	0.92	0.9	0.99	0.9	0.96	0.89	0.9	0.9	0.93	0.98	0.93	0.14	0.92	0.9	0.78	0.89	0.93	0.89	0.6	0.97		0.95	-0.17	0.99	0.98
Other Liab	0.91	0.91	0.96	0.89	0.84	0.87	0.84	0.91	0.92	0.91	0.91	0.14	0.87	0.85	0.77	0.91	0.89	0.91	0.53	0.9	0.95		-0.42	0.96	0.87
Net Tangible Assets	-0.35	-0.49	-0.19	-0.33	0.0	-0.36	-0.19	-0.49	-0.36	-0.11	-0.36	0.0	-0.23	-0.31	-0.22	-0.48	-0.26	-0.48	-0.17	-0.11	-0.17	-0.42		-0.27	-0.05
Accounts Payable	0.94	0.93	0.99	0.92	0.95	0.92	0.91	0.93	0.96	0.98	0.95	0.13	0.93	0.92	0.79	0.93	0.94	0.93	0.62	0.97	0.99	0.96	-0.27		0.97
Deferred Long Term Liab	0.91	0.88	0.97	0.89	0.99	0.87	0.91	0.87	0.92	0.98	0.91	0.16	0.93	0.91	0.78	0.88	0.92	0.88	0.65	0.98	0.98	0.87	-0.05	0.97

Click cells to compare fundamentals

Sartorius Stedim Account Relationship Matchups

Sartorius Stedim balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Current Liabilities	428.4M	567.8M	1.0B	1.0B	1.2B	642.1M
Retained Earnings	899.4M	1.2B	1.4B	2.2B	2.5B	1.3B
Other Assets	181.6M	265.2M	456.5M	712.8M	819.7M	860.7M
Net Receivables	242.6M	264.0M	371.7M	419.7M	482.7M	303.2M
Inventory	329.0M	471.0M	783M	1.0B	1.2B	1.2B
Other Current Assets	28.1M	69.3M	64.6M	94.8M	109.0M	114.5M
Other Stockholder Equity	240.9M	210.4M	240.2M	251.9M	289.7M	190.2M
Total Current Assets	636.2M	873.9M	1.5B	1.7B	1.9B	2.0B
Property Plant Equipment	470.1M	518.6M	640.2M	808M	929.2M	516.2M
Other Current Liab	216.1M	309.2M	648.1M	686.3M	789.2M	441.6M
Other Liab	144.0M	264.8M	595.6M	403.6M	464.1M	328.8M
Net Tangible Assets	615.7M	239.1M	271.9M	600.8M	540.7M	362.9M
Accounts Payable	117.1M	174.7M	251.4M	251.5M	289.2M	197.6M
Deferred Long Term Liab	83.8M	98.1M	120.9M	164.2M	188.8M	117.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

BTC	Bitcoin
TRX	TRON
BNB	Binance Coin

Additional Tools for Sartorius Stock Analysis

When running Sartorius Stedim's price analysis, check to measure Sartorius Stedim's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sartorius Stedim is operating at the current time. Most of Sartorius Stedim's value examination focuses on studying past and present price action to predict the probability of Sartorius Stedim's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sartorius Stedim's price. Additionally, you may evaluate how the addition of Sartorius Stedim to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC